Clincosm LogoSign in Get a demo

head and neck squamous cell carcinoma

Showing 51 - 75 of 321
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • PET/CT
  • Neck dissection
  • (no location specified)
Jan 31, 2023

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Magrolimab, Pembrolizumab, Docetaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Chandler, Arizona
  • +59 more
Jan 20, 2023

Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +8 more
  • XmAb®808
  • Keytruda® (pembrolizumab)
  • Denver, Colorado
  • +2 more
Jan 19, 2023

Head and Neck Squamous Cell Carcinoma Trial in Villejuif (Nasofibroscopy, Low Dose Chest CTscan, injected CT-scan)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nasofibroscopy
  • +5 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jan 19, 2023

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jan 19, 2023

Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 18, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Portland (drug, radiation, procedure)

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Portland, Oregon
  • +1 more
Jan 18, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Head and Neck Squamous Cell Carcinoma Trial in Toronto (MET-4)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Head and Neck Squamous Cell Carcinoma Trial in Houston (Stereotactic body radiotherapy, Traditional Palliation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Stereotactic body radiotherapy
  • Traditional Palliation
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (Buprenorphine, Tramadol, Oral Mucositis (OM) Pain App)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jan 4, 2023

Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)

Active, not recruiting
  • Squamous Cell Lung Cancer
  • +5 more
  • pembrolizumab; vorinostat
  • Angers, France
  • +13 more
Jan 4, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in San Antonio (SRF114)

Recruiting
  • Advanced Solid Tumor
  • Head and Neck Squamous Cell Carcinoma
  • San Antonio, Texas
    START- San Antonio
Jan 2, 2023

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Squamous Cell Carcinoma,

Active, not recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +19 more
  • Cetuximab
  • +5 more
  • Birmingham, Alabama
  • +255 more
Dec 30, 2022

Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Dec 20, 2022

Head and Neck Squamous Cell Carcinoma Trial (pembrolizumab+cisplatin + 5-fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • pembrolizumab+cisplatin + 5-FU
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Dec 26, 2022

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +9 more
Dec 22, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022